Diffusion-Weighted MRI for Liver Metastasis

Completed

Conditions studied: Colorectal Cancer, Colon Cancer Liver Metastasis, Malignant Neoplasm of Rectum Metastatic to Liver

In brief

The DREAM study will assess the diagnostic accuracy of diffusion-weighted MRI in combination with other imaging modalities (multiparametric MRI and CT Scan) in determining the true status of disappearing liver metastasis (DLM) detected after conversion systemic therapy for unresectable or borderline resectable colorectal liver metastasis (CRLM).

Key facts

Study ID
NCT02781935
Run by
European Organisation for Research and Treatment of Cancer - EORTC
People needed
233
Starts
2016-11-01
Expected to finish
2023-09-27
Last updated by the study team
2024-01-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.